Skip to content

Clinical study on the treatment of hypertension and diabetic retinopathy by Yiqi Kaixuan comprehensive program

Clinical study on the treatment of hypertension and diabetic retinopathy by Yiqi Kaixuan comprehensive program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000086
Enrollment
Unknown
Registered
2025-01-13
Start date
2025-01-15
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy

Interventions

Observation group:On the basis of the use of the basic treatment plan we are given Vermicosaurus Huoxue Tongyu Capsules.
Primary treatment group:The basic treatment plan was formulated according to the relevant opinions of the "2011 Guidelines for the Prevention and Treatment of Diabetic Retinopathy in Traditional Chine

Sponsors

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) The patient was diagnosed with retinopathy by ophthalmology; 2) After examination rule out other organic eye diseases such as cataract glaucoma etc.; (3) Patients aged between 30 and 75 years old without serious systemic diseases were enrolled and stopped the drugs and other treatments that affected the efficacy observation of this study; (4) Inclusion criteria of the control group: meeting (1) (2) (3) and not accompanied by hypertension and diabetes; (5) Inclusion criteria for the diabetes group: it met (1) (2) and (3) and the diagnosis of diabetes mellitus and diabetic retinopathy (DR) and the international clinical classification of DR Was between mild and severe without hypertension; Hypertension group inclusion criteria: meet (1) (2) (3) and have a diagnosis of hypertension and do not have diabetes; The inclusion criteria of diabetes + hypertension group: meet (1) (2) (3) and the diagnosis of diabetes and diabetic retinopathy (DR) the international clinical classification of DR Is between mild and severe and meet the diagnostic criteria of hypertension; Blood sugar control is relatively stable (HBA1c is controlled below 7%); 9) Good compliance signed informed consent;

Exclusion criteria

Exclusion criteria: 1)Patients with other eye diseases (such as glaucoma moderate to severe cataract affecting fundus examination or other diseases that hinder the observation of fundus etc.); 2) Allergic patients who were allergic to sodium fluorescein injection and could not undergo fundus photography and fundus fluorescence angiography; 3) Patients with serious cardiovascular cerebrovascular liver or hematopoietic system diseases; 4) Patients with renal failure complicated with diabetic nephropathy; 5)Women and children who are breastfeeding pregnant or preparing to become pregnant cannot cooperate with treatment; 6) Patients who cannot follow medical instructions poor compliance hysteria or mental disorders; 7)Patients who are also participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
OCT examination;sight;Blood pressure;Low vision Quality of Life Scale;Fundus photography;

Secondary

MeasureTime frame
Self-efficacy scales;Cardiac speckle tracking imaging techniques;TCM Elements and Symptom Scores;

Countries

China

Contacts

Public ContactPing Liu

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University

helloliuping@163.com13378250818

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026